Overview

Update
Status
Biolex Therapeutics has been closed
Total Equity Funding
$178.4M in 6 Rounds from 20 Investors
Headquarters:
Pittsboro, NC
Description:
Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.biolex.com

Company Details

Update

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates. Their main product aims at treating those afflicted with Hepatitis C.

Funding Rounds (9) - $196.66M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2011$2.36M / Debt Financing0
Jun, 2011$5.9M / Debt Financing0
Oct, 2010$20M / Series D0
Feb, 2010$10M / Debt Financing0
Oct, 2008$60M / Series D11
May, 2007$30M / Series C9
Sep, 2005$36M / Series B6
Jan, 2005$8M / Venture1
Aug, 2003$24.4M / Venture12

Acquisitions (1)

Update
DateAcquiredAmount
May 7, 2004Unknown

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Headquarters

    158 Credle Street

    Pittsboro, NC 27312

    USA

Images (1)

Update

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos